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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S336risk of injury. Thereby, the present ﬁnding could indicate that GJH may
be an important risk factor for knee injuries and later development of
OA.
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KNEE EXTENSOR MUSCLE WEAKNESS INCREASES THE RISK OF KNEE
OSTEOARTHRITIS. A SYSTEMATIC REVIEW AND META-ANALYSIS
B.E. Øiestad y, C.B. Juhl z, I. Eizen x, J.B. Thorlund z. yNorwegian research
center for Active Rehabilitation (NAR), Oslo Univ. Hosp., Oslo, Norway;
zRes. Unit for Musculoskeletal Function and Physiotherapy, Univ. of
Southern Denmark, Odense, Denmark; xUniv. Hosp. Oslo, Dept. of
Orthopædics, Oslo, Norway
Purpose: Previous studies including systematic reviews have suggested
that knee extensor muscle weakness is a risk factor for the development
of knee osteoarthritis (OA). However, systematic reviews have not
aggregated the reported data into a meta-analysis. The aim of this study
was to estimate the impact of knee extensor muscle weakness on the
risk of knee OA.
Methods: A systematic review and meta-analysis was performed with
literature searches in Medline, SportsDiscus, EMBASE, CINAHL, and
AMED, all up to September 2013. Furthermore reference lists and sys-
tematic reviews on the topic were scrutinized for additional relevant
studies. No restriction on language or publication year was made. Eli-
gible studies had to include participants with no radiographic or
symptomatic knee OA at baseline, and have a follow-up time of mini-
mum 2 years. Studies had to include a measure of knee extensor muscle
strength. Participants were classiﬁed as having knee extensor muscle
weakness if they belonged to the lowest tertile or less in muscle
strength or deﬁned from a leg symmetry index (LSI). If more than one
muscle strength outcome or knee OA deﬁnition were reported, a pre-
deﬁned hierarchy for extracting data was used. The hierarchy was: 1)
Symptomatic radiographic knee OA for the whole knee, 2) Radiographic
knee OA, and 3) Self-reported OA. Peak knee extensor muscle strength
per kg body weight was preferred as measure of muscle strength;
secondly average knee peak torque was extracted. Odds ratio (OR) for
knee OA at follow-upwas estimated in the included trials and combined
using a random effects model. Stratiﬁed analysis for men and women
were performed.
Results: A total of 1000 studies were identiﬁed thorough the literature
searches. After review, four cohort studies with a follow-up time
between 2.5 and 14 years were included. A total of 5102 participants
(3325 men and 1777 women) were included in the ﬁnal analysis. The
studies included different groups of participants; middle-aged indi-
viduals with and without previous knee injury, elderly individuals
without previous knee injury, as well as younger anterior cruciate lig-
ament reconstructed (ACLR) individuals. Weakmuscle strengthwas in 2
trials deﬁned as being in the lowest tertile, when assessing the iso-
kinetic knee extensor muscle strength. In one trial low muscle strength
was deﬁned as having a leg symmetry index of less than 80% (muscle
strength in the affected leg was less than 80% of the muscle strength in
the non-affected leg). Finally in one trial only data on the differences in
muscle strength between patients with and without OA was available.
Overall the meta-analysis showed an increased risk of knee OA in par-
ticipants with knee extensor muscle weakness (OR 1.54 95%CI 1.28,
1.88; I2 ¼ 14.5%). Three trials reported separate data for men and
women and subgroup analysis showed increased risk in men (OR 1.43
95%CI 1.14, 1.78; I2 ¼ 0%) and women (OR 1.79 95%CI 1.37, 2.31; I2 ¼
3.3%), but differences in risk between men and women did not reach
statistical signiﬁcance (P¼0.200).
Conclusions: Knee extensor weakness increased the risk of having knee
OA at follow-up. Even though not statistically signiﬁcant, the analysis
indicated that weak knee extensor strength seems to be a stronger risk
factor for OA in women than in men.
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RISK FACTORS FOR MAGNETIC RESONANCE IMAGING DIAGNOSED
PATELLAR TENDINOPATHY IN COMMUNITY-BASED MIDDLE-AGED
WOMEN
J. Toppi, J. Fairley, F. Cicuttini, J. Cook, S. Davis, R. Bell, F. Hanna,
Y. Wang. Monash Univ., Melbourne, AustraliaPurpose: Patellar tendinopathy, a condition that causes activity-related
anterior knee pain, has diagnostic magnetic resonance imaging (MRI)
features. The aim of this study was to examine the prevalence and risk
factors for MRI-diagnosed patellar tendinopathy in community-based
middle-aged women.
Methods: 176 women, aged 40-67 years, with no signiﬁcant knee pain
or injury underwent knee MRI. An MRI diagnosis of patellar tendin-
opathy was made if an area of increased signal intensity was seen in the
proximal inferior patellar tendon region on at least 2 adjacent slices on
both T1- and T2-weighted images. The cross-sectional area of vastus
medialis was measured fromMRI. Height and weight were measured to
calculate body mass index (BMI). Physical activity was assessed using a
questionnaire. Serum concentrations of C-reactive protein, androste-
nedione, dehydroepiandrosterone sulphate, testosterone, and sex hor-
mone binding globulin (SHBG) were measured.
Results: The prevalence of MRI-diagnosed patellar tendinopathy was
30.1%. Higher levels of physical activity (odds ratio 1.65, 95% CI 1.09-
2.51) and greater vastus medialis cross-sectional area (odds ratio 1.22,
95% CI 1.04-1.43) were associated with increased prevalence of patellar
tendinopathy, independent of age and BMI. There were no associations
with C-reactive protein, the sex steroids or SHBG.
Conclusion: In community-based middle-aged women MRI-diag-
nosed patellar tendinopathy is common, with higher levels of
physical activity and greater vastus medialis size being risk factors.
The ﬁndings highlight the importance of mechanical factors in the
pathogenesis of patellar tendinopathy. Further work is needed to
determine the contribution of patellar tendinopathy to knee pain
and function.OA: cartilage and bone
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PROGRANULIN A CHONDROPROTECTIVE GROWTH FACTOR IN THE
PATHOGENESIS OF OSTEOARTHEITIS
B.S. Richbourgh, C. Liu, Y. Zhao, B. Liu. NYU Sch. of Med., New York, NY,
USA
Purpose: The objective of this study is to determine the role of PGRN in
human chondrocyte metabolism in vitro and in the course of OA pro-
gression in vivo, as well as the molecular mechanisms involved.
Method: Human chondrocytes and cartilage explants were isolated
from OA patients. The isolated chondrocytes were cultured in the
presence of TNF-a, PGRN, or both. Three days after treatment, cells and
explants were collected and analyzed for anabolic and catabolic mark-
ers. Approaches for evaluating cartilage metabolism, including Safra-
nin-O staining, immunohistochemistry, ELISA and Western blotting,
were performed. A destabilization of medial meniscus (DMM) surgically
induced murine model was generated with both wildtype and PGRN
deﬁcient mice. For testing the effect of recombinant PGRN in severe OA
the ACL model was used. OA severity was evaluated using histological
assay (e.g. Safranin-O staining), degradation of cartilage extracellular
matrix molecules, and osteophyte formation.
Results: TNF-a dramatically reduced the levels of anabolic markers and
enhanced the levels of catabolic markers including MMP13, ADAMTS-5,
iNOS and COX-2, (Figure.1) while this alteration was largely abolished
by additional treatment of PGRN, suggesting PGRNs protective role
against human cartilage degeneration. Our results also demonstrated
that PGRN greatly stimulates anabolic makers, including Aggrecan and
Collagen type 2. (Figure.2). Histological analysis of cartilage isolated
from DMM model revealed (Figure.3) signiﬁcantly increased cartilage
degradation in PRGN-/- mice relative toWT. Safranin O staining showed
little or no proteoglycans in PRGN -/- mice along with signiﬁcantly
increased serum COMP fragment levels. Intra-articular injection of
PRGN signiﬁcantly reduced the degeneration of cartilage in surgically
induced ACL model in WT mice, reﬂected by histological analysis of
cartilage. In the ACL model 4 weeks-post surgery, PRGN treated mice
retained cartilage integrity and showed little or no degradation of car-
tilage matrix in comparison to highly degraded cartilage of non-treated
mice. Collectively, PRGN deﬁcient mice develop more severe OA
whereas treatment with PRGNmarkedly delays the progression of OA in
WT mice.
